Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Trefzer

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
The Journal of Investigative Dermatology|November 1, 1993
In situ expression of a B7-like adhesion molecule on keratinocytes from human epidermisT E Fleming, W S Mirando, U Trefzer, et al.
Cancer Research|February 24, 2001
Expression of cyclooxygenase 2 in human malignant melanomaC Denkert, M Köbel, S Berger, et al.
Ecancermedicalscience|January 26, 2012
Cancer stem cells in melanomaC Regenbrecht, Y Welte, R Hugel, et al.
The Journal of Investigative Dermatology|June 1, 1992
Ultraviolet radiation effects on human keratinocyte ICAM-1 expression: UV-induced inhibition of cytokine-induced ICAM-1 mRNA expression is transient, differentially restored for IFN gamma versus TNF alpha, and followed by ICAM-1 induction via a TNF alpha-like pathwayJ Krutmann, W Czech, F Parlow, et al.
Experimental Dermatology|June 1, 1996
In situ changes in the relative abundance of human epidermal cytokine messenger RNA levels following exposure to the poison ivy/oak contact allergen urushiolK D Boehm, J K Yun, K P Strohl, et al.
Archives of Dermatological Research|December 1, 1996
IL-7 mRNA is not overexpressed in mycosis fungoides and pleomorphic T-cell lymphoma and is likely to be an autocrine growth factor in vivoK Asadullah, A Haeussler, M Friedrich, et al.
Advances in Experimental Medicine and Biology|February 23, 1999
A phase I trial with a hybrid cell vaccine in patients with metastatic melanomaU Trefzer, G Weingart, Y Chen, et al.
International Journal of Cancer|March 4, 2000
Hybrid cell vaccination for cancer immune therapy: first clinical trial with metastatic melanomaU Trefzer, G Weingart, Y Chen, et al.
The Journal of Clinical Investigation|July 1, 1993
The 55-kD tumor necrosis factor receptor on human keratinocytes is regulated by tumor necrosis factor-alpha and by ultraviolet B radiationU Trefzer, M Brockhaus, H Lötscher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 29, 2006
Dose-intensified bi-weekly temozolomide in patients with asymptomatic brain metastases from malignant melanoma: a phase II DeCOG/ADO studyD Schadendorf, A Hauschild, S Ugurel, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
The Journal of Investigative Dermatology|November 1, 1993
In situ expression of a B7-like adhesion molecule on keratinocytes from human epidermisT E Fleming, W S Mirando, U Trefzer, et al.
Cancer Research|February 24, 2001
Expression of cyclooxygenase 2 in human malignant melanomaC Denkert, M Köbel, S Berger, et al.
Ecancermedicalscience|January 26, 2012
Cancer stem cells in melanomaC Regenbrecht, Y Welte, R Hugel, et al.
The Journal of Investigative Dermatology|June 1, 1992
Ultraviolet radiation effects on human keratinocyte ICAM-1 expression: UV-induced inhibition of cytokine-induced ICAM-1 mRNA expression is transient, differentially restored for IFN gamma versus TNF alpha, and followed by ICAM-1 induction via a TNF alpha-like pathwayJ Krutmann, W Czech, F Parlow, et al.
Experimental Dermatology|June 1, 1996
In situ changes in the relative abundance of human epidermal cytokine messenger RNA levels following exposure to the poison ivy/oak contact allergen urushiolK D Boehm, J K Yun, K P Strohl, et al.
Archives of Dermatological Research|December 1, 1996
IL-7 mRNA is not overexpressed in mycosis fungoides and pleomorphic T-cell lymphoma and is likely to be an autocrine growth factor in vivoK Asadullah, A Haeussler, M Friedrich, et al.
Advances in Experimental Medicine and Biology|February 23, 1999
A phase I trial with a hybrid cell vaccine in patients with metastatic melanomaU Trefzer, G Weingart, Y Chen, et al.
International Journal of Cancer|March 4, 2000
Hybrid cell vaccination for cancer immune therapy: first clinical trial with metastatic melanomaU Trefzer, G Weingart, Y Chen, et al.
The Journal of Clinical Investigation|July 1, 1993
The 55-kD tumor necrosis factor receptor on human keratinocytes is regulated by tumor necrosis factor-alpha and by ultraviolet B radiationU Trefzer, M Brockhaus, H Lötscher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 29, 2006
Dose-intensified bi-weekly temozolomide in patients with asymptomatic brain metastases from malignant melanoma: a phase II DeCOG/ADO studyD Schadendorf, A Hauschild, S Ugurel, et al.
Pageof 5